Philip L. Johnson

Philip L. Johnson

Executive Vice President and CFOatJazz Pharmaceuticals· In proxies 2024–2025

Pay in FY2025+44% from the year before · Jazz Pharmaceuticals stock +38.0% the same year

Philip L. Johnson was paid $7.5M in FY2025 (Dec), up 44%. Jazz Pharmaceuticals stock rose 38.0% that year.

Pay$100 in the stock at the end of FY23 → $138
Pay is from the Summary Compensation Table of each Jazz Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Jazz PharmaceuticalsPublic company · 2 yr
    • Executive Vice President and CFO2024 – Present · 2 yrStock in role +69%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?